UiPath (NYSE:PATH – Free Report) had its price target decreased by Morgan Stanley from $16.00 to $12.00 in a report published ...
UiPath (NYSE:PATH – Free Report) had its price objective lowered by Royal Bank of Canada from $16.00 to $13.00 in a research ...